BCHE and dementia: Apart from Donepezil, Rivastigmine (13.63%) was found to be the second most popular choice of drug for dementia patients, Galantamine was preferred for 12.4% of the population, and combination of choline-esterase inhibitor, that is, Donepezil and Memantine was used in 6.43%.